series-c-plus
Stage
1
Investors
About
Solid Biosciences is a biotechnology company developing therapies for Duchenne muscular dystrophy, focusing on gene therapy and genetic medicine to address this rare inherited muscle disease.
Explore Solid Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.